Pediatric primary lung adenocarcinoma in the absence of congenital pulmonary airway malformation

Achuta Kumar Guddati, Creticus P. Marak

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Primary lung adenocarcinoma is a rare entity in the pediatric population, especially in the absence of an underlying congenital pulmonary airway malformation. Primary lung malignancies in pediatric patients are rare and constitute 0.2 % of all childhood malignancies. EGFR mutations and congenital airway malformations have been identified as etiological factors in the development of precancerous lesions that eventually progress to malignancy. The availability of genome sequencing and advanced imaging has made it possible to associate primary lung adenocarcinoma with mutations and structural malformations. Early diagnosis with the help of these techniques may result in surgical resection during early stages of the disease and possibly provide definitive treatment. Development of lung adenocarcinoma in pediatric patients in the absence of the above factors has been recorded anecdotally. It is possible that these patients may harbor a yet unknown set of mutations and recording this cases and preserving their tissues is of vital importance in the detection of these yet unknown etiologies.

Original languageEnglish (US)
Pages (from-to)2661-2663
Number of pages3
JournalMedical Oncology
Volume29
Issue number4
DOIs
StatePublished - Dec 1 2012

Fingerprint

Pediatrics
Lung
Mutation
Neoplasms
Early Diagnosis
Genome
Population
Adenocarcinoma of lung
Therapeutics

Keywords

  • CPAM
  • Congenital
  • Lung adenocarcinoma
  • Pediatric

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Pediatric primary lung adenocarcinoma in the absence of congenital pulmonary airway malformation. / Guddati, Achuta Kumar; Marak, Creticus P.

In: Medical Oncology, Vol. 29, No. 4, 01.12.2012, p. 2661-2663.

Research output: Contribution to journalArticle

@article{f80afa12ea874cdc856f2967d420b6df,
title = "Pediatric primary lung adenocarcinoma in the absence of congenital pulmonary airway malformation",
abstract = "Primary lung adenocarcinoma is a rare entity in the pediatric population, especially in the absence of an underlying congenital pulmonary airway malformation. Primary lung malignancies in pediatric patients are rare and constitute 0.2 {\%} of all childhood malignancies. EGFR mutations and congenital airway malformations have been identified as etiological factors in the development of precancerous lesions that eventually progress to malignancy. The availability of genome sequencing and advanced imaging has made it possible to associate primary lung adenocarcinoma with mutations and structural malformations. Early diagnosis with the help of these techniques may result in surgical resection during early stages of the disease and possibly provide definitive treatment. Development of lung adenocarcinoma in pediatric patients in the absence of the above factors has been recorded anecdotally. It is possible that these patients may harbor a yet unknown set of mutations and recording this cases and preserving their tissues is of vital importance in the detection of these yet unknown etiologies.",
keywords = "CPAM, Congenital, Lung adenocarcinoma, Pediatric",
author = "Guddati, {Achuta Kumar} and Marak, {Creticus P.}",
year = "2012",
month = "12",
day = "1",
doi = "10.1007/s12032-012-0219-7",
language = "English (US)",
volume = "29",
pages = "2661--2663",
journal = "Medical Oncology",
issn = "1357-0560",
publisher = "Humana Press",
number = "4",

}

TY - JOUR

T1 - Pediatric primary lung adenocarcinoma in the absence of congenital pulmonary airway malformation

AU - Guddati, Achuta Kumar

AU - Marak, Creticus P.

PY - 2012/12/1

Y1 - 2012/12/1

N2 - Primary lung adenocarcinoma is a rare entity in the pediatric population, especially in the absence of an underlying congenital pulmonary airway malformation. Primary lung malignancies in pediatric patients are rare and constitute 0.2 % of all childhood malignancies. EGFR mutations and congenital airway malformations have been identified as etiological factors in the development of precancerous lesions that eventually progress to malignancy. The availability of genome sequencing and advanced imaging has made it possible to associate primary lung adenocarcinoma with mutations and structural malformations. Early diagnosis with the help of these techniques may result in surgical resection during early stages of the disease and possibly provide definitive treatment. Development of lung adenocarcinoma in pediatric patients in the absence of the above factors has been recorded anecdotally. It is possible that these patients may harbor a yet unknown set of mutations and recording this cases and preserving their tissues is of vital importance in the detection of these yet unknown etiologies.

AB - Primary lung adenocarcinoma is a rare entity in the pediatric population, especially in the absence of an underlying congenital pulmonary airway malformation. Primary lung malignancies in pediatric patients are rare and constitute 0.2 % of all childhood malignancies. EGFR mutations and congenital airway malformations have been identified as etiological factors in the development of precancerous lesions that eventually progress to malignancy. The availability of genome sequencing and advanced imaging has made it possible to associate primary lung adenocarcinoma with mutations and structural malformations. Early diagnosis with the help of these techniques may result in surgical resection during early stages of the disease and possibly provide definitive treatment. Development of lung adenocarcinoma in pediatric patients in the absence of the above factors has been recorded anecdotally. It is possible that these patients may harbor a yet unknown set of mutations and recording this cases and preserving their tissues is of vital importance in the detection of these yet unknown etiologies.

KW - CPAM

KW - Congenital

KW - Lung adenocarcinoma

KW - Pediatric

UR - http://www.scopus.com/inward/record.url?scp=84868001966&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84868001966&partnerID=8YFLogxK

U2 - 10.1007/s12032-012-0219-7

DO - 10.1007/s12032-012-0219-7

M3 - Article

C2 - 22447504

AN - SCOPUS:84868001966

VL - 29

SP - 2661

EP - 2663

JO - Medical Oncology

JF - Medical Oncology

SN - 1357-0560

IS - 4

ER -